Figure 10.
Evaluation of the diagnostic performance of lncRNA-based Index I in the external phase. (A) The ability of the lncRNA-based panel to differentiate patients with GC and individuals with precancerous lesions (Prec). (B) The ability of the lncRNA-based panel to differentiate patients with GC and individuals with gastrointestinal stromal tumor (GIST).